BNY
Mellon
Women’s
Opportunities
ETF
Statement
of
Investments
May
31,
2025
(Unaudited)
Description
Shares
Value
($)
Common
Stocks
–
99.0%
Banks
–
7.6%
Bank
of
America
Corp.
7,062
311,646
First
Horizon
Corp.
10,673
212,179
JPMorgan
Chase
&
Co.
2,534
668,976
1,192,801
Capital
Goods
–
6.3%
Axon
Enterprise,
Inc.
(a)
300
225,108
GE
Vernova,
Inc.
415
196,287
Hubbell,
Inc.
415
161,676
Trane
Technologies
PLC
954
410,477
993,548
Commercial
&
Professional
Services
–
1.6%
Veralto
Corp.
2,553
257,930
Consumer
Discretionary
Distribution
&
Retail
–
7.5%
Amazon.com,
Inc.
(a)
4,815
987,123
The
TJX
Companies,
Inc.
1,440
182,736
1,169,859
Consumer
Services
–
2.0%
Bright
Horizons
Family
Solutions,
Inc.
(a)
2,426
313,439
Consumer
Staples
Distribution
&
Retail
–
1.8%
Walmart,
Inc.
2,859
282,240
Energy
–
2.8%
Diamondback
Energy,
Inc.
866
116,521
EQT
Corp.
4,132
227,797
Phillips
66
811
92,032
436,350
Financial
Services
–
4.7%
CME
Group,
Inc.
789
228,021
Mastercard,
Inc.,
Class
A
882
516,499
744,520
Health
Care
Equipment
&
Services
–
8.7%
Abbott
Laboratories
1,878
250,863
Addus
HomeCare
Corp.
(a)
1,278
141,743
Alcon
AG
1,917
164,747
Boston
Scientific
Corp.
(a)
4,123
433,987
DexCom,
Inc.
(a)
2,387
204,805
Intuitive
Surgical,
Inc.
(a)
297
164,045
1,360,190
Household
&
Personal
Products
–
3.1%
Kenvue,
Inc.
7,089
169,214
The
Procter
&
Gamble
Company
1,884
320,073
489,287
Insurance
–
2.3%
Aon
PLC,
Class
A
558
207,621
Assurant,
Inc.
755
153,250
360,871
Media
&
Entertainment
–
5.8%
Meta
Platforms,
Inc.,
Class
A
998
646,195
The
Walt
Disney
Company
2,331
263,496
909,691
Pharmaceuticals,
Biotechnology
&
Life
Sciences
–
5.8%
AbbVie,
Inc.
2,428
451,875
AstraZeneca
PLC,
ADR
2,884
210,042
Statement
of
Investments
(continued)
See
Notes
to
Statement
of
Investments
Description
Shares
Value
($)
Common
Stocks
–
99.0%
(continued)
Pharmaceuticals,
Biotechnology
&
Life
Sciences
–
5.8%
(continued)
Avantor,
Inc.
(a)
10,640
137,362
Natera,
Inc.
(a)
752
118,613
917,892
Real
Estate
Management
&
Development
–
0.9%
CoStar
Group,
Inc.
(a)
2,001
147,194
Semiconductors
&
Semiconductor
Equipment
–
11.0%
Micron
Technology,
Inc.
1,977
186,747
NVIDIA
Corp.
10,197
1,377,921
Texas
Instruments,
Inc.
851
155,605
1,720,273
Software
&
Services
–
18.7%
HubSpot,
Inc.
(a)
536
316,186
Intuit,
Inc.
558
420,436
Microsoft
Corp.
2,977
1,370,492
ServiceNow,
Inc.
(a)
222
224,462
Shopify,
Inc.,
Class
A
(a)
2,882
309,008
Synopsys,
Inc.
(a)
389
180,488
Workday,
Inc.,
Class
A
(a)
456
112,956
2,934,028
Technology
Hardware
&
Equipment
–
4.3%
Apple,
Inc.
3,348
672,446
Transportation
–
1.2%
Uber
Technologies,
Inc.
(a)
2,235
188,098
Utilities
–
2.9%
Constellation
Energy
Corp.
878
268,800
Dominion
Energy,
Inc.
3,273
185,481
454,281
Total
Common
Stocks
(cost
$11,619,755)
15,544,938
Investment
Companies
–
1.0%
Registered
Investment
Companies
–
1.0%
Dreyfus
Institutional
Preferred
Government
Money
Market
Fund,
Institutional
Shares,
4.28%
(b)(c)
(cost
$152,338)
152,338
152,338
Total
Investments
(cost
$11,772,093)
100.0%
15,697,276
Cash
and
Receivables
(Net)
0.0%
2,692
Net
Assets
100.0%
15,699,968
ADR—American
Depositary
Receipt
(a)
Non-income
producing
security.
(b)
Investment
in
affiliated
issuer.
The
investment
objective
of
this
investment
company
is
publicly
available
and
can
be
found
within
the
investment
company’s
prospectus.
(c)
The
rate
shown
is
the
1-day
yield
as
of
May
31,
2025.
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
The
Financial
Accounting
Standards
Board
(“FASB”)
Accounting
Standards
Codification
(“ASC”)
is
the
exclusive
reference
of
authoritative
U.S.
generally
accepted
accounting
principles
(“GAAP”)
recognized
by
the
FASB
to
be
applied
by
nongovernmental
entities.
Rules
and
interpretive
releases
of
the
Securities
and
Exchange
Commission
(“SEC”)
under
authority
of
federal
laws
are
also
sources
of
authoritative
GAAP
for
SEC
registrants. BNY
Mellon
Women's
Opportunities
ETF (the
“fund”)
is an
investment
company
and
applies
the
accounting
and
reporting
guidance
of
the
FASB
ASC
Topic
946
Financial
Services-Investment
Companies. The
fund’s
financial
statements
are
prepared
in
accordance
with
GAAP,
which
may
require
the
use
of
management
estimates
and
assumptions.
Actual
results
could
differ
from
those
estimates.
(a)
Portfolio
valuation:
The
fair
value
of
a
financial
instrument
is
the
amount
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date
(i.e.,
the
exit
price).
GAAP
establishes
a
fair
value
hierarchy
that
prioritizes
the
inputs
of
valuation
techniques
used
to
measure
fair
value.
This
hierarchy
gives
the
highest
priority
to
unadjusted
quoted
prices
in
active
markets
for
identical
assets
or
liabilities
(Level
1
measurements)
and
the
lowest
priority
to
unobservable
inputs
(Level
3
measurements).
Additionally,
GAAP
provides
guidance
on
determining
whether
the
volume
and
activity
in
a
market
has
decreased
significantly
and
whether
such
a
decrease
in
activity
results
in
transactions
that
are
not
orderly.
GAAP
requires
enhanced
disclosures
around
valuation
inputs
and
techniques
used
during
annual
and
interim
periods.
Various
inputs
are
used
in
determining
the
value
of
the
fund’s
investments
relating
to
fair
value
measurements.
These
inputs
are
summarized
in
the
three
broad
levels
listed
below:
Level
1
—
unadjusted
quoted
prices
in
active
markets
for
identical
investments.
Level
2
—
other
significant
observable
inputs
(including
quoted
prices
for
similar investments,
interest
rates,
prepayment
speeds,
credit
risk,
etc.).
Level
3
—
significant
unobservable
inputs
(including
the
fund’s
own
assumptions
in
determining
the
fair
value
of
investments).
The
inputs
or
methodology
used
for
valuing
securities
are
not
necessarily
an
indication
of
the
risk
associated
with
investing
in
those
securities.
Changes
in
valuation
techniques
may
result
in
transfers
in
or
out
of
an
assigned
level
within
the
disclosure
hierarchy.
Valuation
techniques
used
to
value
the
fund’s
investments
are
as
follows:
BNY
Mellon
ETF
Trust’s
(the
“Trust”) Board
of
Trustees
(the
“Board”)
has
designated
the
Adviser
as
the
fund’s
valuation
designee
to
make
all
fair
value
determinations
with
respect
to
the
fund’s
portfolio
of
investments,
subject
to
the
Board’s
oversight
and
pursuant
to
Rule
2a-5
under
the
Act.
Investments
in
equity
securities,
including
ETFs
(but
not
including
investments
in
other
open-end
registered
investment
companies),
generally
are
valued
at
the
last
sales
price
on
the
day
of
valuation
on
the
securities
exchange
or
national
securities
market
on
which
such
securities
primarily
are
traded.
Securities
listed
on
the
National
Association
of
Securities
Dealers
Automated
Quotation
System
(“NASDAQ”)
for
which
market
quotations
are
available
will
be
valued
at
the
official
closing
price.
If
there
are
no
transactions
in
a
security,
or
no
official
closing
prices
for
a
NASDAQ
market-listed
security
on
that
day,
the
security
will
be
valued
at
the
average
of
the
most
recent
bid
and
asked
prices.
Bid
price
is
used
when
no
asked
price
is
available.
Open
short
positions
for
which
there
is
no
sale
price
on
a
given
day
are
valued
at
the
lowest
asked
price.
Registered
investment
companies
that
are
not
traded
on
an
exchange
are
valued
at
their
net
asset
value.
All
of
the
preceding
securities
are
generally
categorized
within
Level
1
of
the
fair
value
hierarchy.
When
market
quotations
or
official
closing
prices
are
not
readily
available,
or
are
determined
not
to
reflect
fair
value
accurately,
they are
valued
at
fair
value
as
determined
in
good
faith
based
on
procedures
approved
by
the
Board.
Fair
value
of
investments
may
be
determined
by
valuation
designee
using
such
information
as
it
deems
appropriate
under
the
circumstances.
Certain
factors
may
be
considered
when
fair
valuing
investments
such
as:
fundamental
analytical
data,
the
nature
and
duration
of
restrictions
on
disposition,
an
evaluation
of
the
forces
that
influence
the
market
in
which
the
securities
are
purchased
and
sold,
and
public
trading
in
similar
securities
of
the
issuer
or
comparable
issuers.
These
securities
are
either
categorized
within
Level
2
or
3
of
the
fair
value
hierarchy
depending
on
the
relevant
inputs
used.
For
securities
where
observable
inputs
are
limited,
assumptions
about
market
activity
and
risk
are
used
and
are
generally
categorized
within
Level
3
of
the
fair
value
hierarchy.
The
table
below
summarizes
the
inputs
used
as
of May
31,
2025
in
valuing
the
fund’s
investments:
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
(continued)
Fair
Value
Measurements
Additional
investment
related
disclosures
are
hereby
incorporated
by
reference
to
the
annual
and
semi-annual
reports
previously
filed
with
the
SEC
on
Form
N-CSR.
At May
31,
2025,
accumulated
net
unrealized
appreciation on
investments
was
$3,925,183,
consisting
of
gross
appreciation
of
$4,086,487
and
gross
depreciation
of
$161,304.
At
May
31,
2025,
the
cost
of
investments
for
federal
income
tax
purposes
was
substantially
the
same
as
the
cost
for
financial
reporting
purposes
(see
the
Statement
of
Investments).
Level
1
-
Unadjusted
Quoted
Prices
Level
2
-
Other
Significant
Observable
Inputs
Level
3
-
Significant
Unobservable
Inputs
Total
Assets
($)
Investments
In
Securities:
†
Common
Stocks
15,544,938
—
—
15,544,938
Investment
Companies
152,338
—
—
152,338
15,697,276
—
—
15,697,276
†
See
Statement
of
Investments
for
additional
detailed
categorizations,
if
any.